Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA.

Slides:



Advertisements
Similar presentations
Neoplasia II: Tumor Characteristics
Advertisements

Atypical ductal hyperplasia “A diagnosis of ADH should not be made unless a diagnosis of low grade DCIS is being seriously considered” WHO Breast 2012.
Mammary ductal carcinoma
Well differentiated squamous cell carcinoma, keratoacanthoma type (Keratoacanthoma): Three cases Deba P Sarma, MD Omaha.
Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
MICROCALCIFICATION IN BENIGN BREAST DISEASE
Development of laboratory models to study Breast Cancer Deborah Holliday Breast Research Group Section of Pathology & Tumour Biology Section of Pathology.
Breast Pathology Helge Stalsberg MD University Hospital of North Norway.
Malignant Adenomyoepithelioma of the Breast with Lymph Node Metastasis
Pathology Journal Reading
American Journal of Surgical Pathology March, 2007 David J. Dabbs, MD, Rohit Bhargava, MD, and Mamatha Chivukula, MD Int. 簡聖軒 Lobular Versus Ductal Breast.
Using the EHR for the identification of patients at high risk for hereditary breast and ovarian cancer. Brian Drohan University of Massachusetts 5/30/08.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Breast Cancer By Kajal Haghmoradi.
Breast Pathology Dr. M. Griffin.
Breast Imaging Made Brief and Simple
Faculty of Medicine - Benha University
Ductal Carcinoma in situ
Ductal Carcinoma In-Situ (DCIS)
Proliferative Epithelial lesions of the Breast
Breast Pathology Seminar CASE PRESENTATION PART 1 Elba Torres Matundan MD FCAP Victor Carlo Vargas MD FCAP.
Elshami M.Elamin, MD Medical Oncologist Central Care Cancer Center Wichita, KS, USA
BREAST CANCER GROUP 6 :  Nuraini Ikqtiarzune Haryono( )  Tri Wahyu Ningsih ( )  Rani Yuswandaru ( )  Anita Rheza Fitriana Putri( )
Marion C.W. Henry, MD Yale University
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Breast Pathology. Breast pathology Inflammatory Disorders Acute Mastitis Preiductal Mastitis Mammary Duct Ectasia Fat Necrosis Lymphocytic Mastopathy.
Breast Cancer and the Environment Taylor Dungjen Beth Rudolph.
Breast Cancer Awareness Marissa Gregg. What is Breast Cancer?  Breast Cancer forms in the breast  It is a tumor in the breast  Breast cancer is the.
Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Russell A. Patterson Affiliation: Uniformed Services University.
Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.
Session 5. Case Diagnosis - Sclerosing adenosis with lobular neoplasia. No invasion in images provided.
Outline Intraductal proliferative lesions
The Breast Clinic Index case Year 2 Michaelmas term.
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Breast Pathology Emad Raddaoui, MD, FCAP, FASC
Katie Ludwig FY1.   50, 285 New cases of breast cancer  11, 716 deaths  78% - 10 year survival rates  27% preventable cases  Source:
بسم الله الرحمن الرحیم. A 74 Y/O female with large right breast mass measured 5.5 x 4.5 x 4 cm.
By: Ashley Rodriguez, Yara parada, Briana Mendoza, Jackie Hernandez
 Among all cancers, breast cancer has been the 2 nd leading cause of death in women (right behind lung cancer)  Causes about 40,000 deaths annually.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Lesioni a cellule colonnari CON atipie (FEA/DIN1A) Lesioni a rischio evolutivo? Escissione sempre? SI ?
The Use of Pathologic Factors to Assist in Establishing Adequacy of Excision Prior to Radiation Therapy in Patients Treated with Breast Conserving Therapy.
Pathology.
W. Scott Campbell, Ph.D., MBA University of Nebraska Medical Center
Educational case 1 Dr JD Hemming Queen Elizabeth Hospital Gateshead.
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
Female Reproductive System Kristine Krafts, M.D..
Jacob J. Adler.  The following slides are meant for students to navigate on their own or in small groups.  They are expected to have time to research.
Deepam Meditours Medical Assistance Tourism Company We will FIGHT against “BREAST CANCER”……. Want to Join us….
Multistep model of breast cancer progression
W. Scott Campbell, MBA, PhD James R. Campbell, MD
Pre neoplastic lesions
Dr.Nik Makretsov, MD, PhD, FRCPC
Ductal carcinoma in situ (DCIS)
BREAST CANCER A full classification includes histopathological type, grade, stage (TNM), receptor status, and the presence or absence of genes as determined.
Patterns of ductal carcinoma in situ (DCIS)
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Columnar cell lesions and atypical ductal hyperplasia
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Ductal carcinoma in situ (DCIS)
معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.
سرطان الثدي Breast Cancer
Handling and Evaluation of Breast Cancer Biopsy
Marion C.W. Henry, MD Yale University
Gene promoter methylation analysis in ductal lavage fluid from cancer-free women at high risk for breast cancer and in women undergoing mastectomy for.
Presentation transcript:

Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA

There are two main types of epithelial cells in the breast: Ductal and Lobular. The distinction is based on how the cells look and how they grow, not necessarily on their location in the breast. So ductal cells can travel into the lobules and lobular cells can travel up the ducts.

Normal breast duct and lobules lobule duct lobule

Let’s start with ductal….

There are three main ductal lesions: 1) ductal hyperplasia, usual type; 2) atypical ductal hyperplasia; and 3) ductal carcinoma in situ Ductal hyperplasiaAtypical ductal hyperplasiaDuctal carcinoma in situ

Ductal hyperplasia, usual type This basically means there are too many ductal cells in the ducts but they are not atypical. Often graded as mild, moderate, or severe (florid). Studies show there is an increased relative risk (1.5-2 times) for the subsequent development of invasive carcinoma with moderate to florid ductal hyperplasia. This risk applies to both breasts.

Ductal hyperplasia: What does it mean if my biopsy shows this? If found on core needle biopsy and the findings are concordant to the radiologist, no need for surgical excision. If found on a surgical excision and nothing more significant is found, no need for the pathologist to comment on margins and no need for surgical re-excision.

Atypical ductal hyperplasia This term describes a proliferation of ductal cells that has “some, but not all” of the features of low grade ductal carcinoma in situ. Studies show there is an increased relative risk (4- 5 times) for the subsequent development of invasive carcinoma. This risk applies to both breasts.

Atypical ductal hyperplasia: What does it mean if my biopsy shows this? If found on core needle biopsy, surgical excision is warranted because of an approximate 20-30% chance of finding carcinoma in situ or invasive carcinoma based on most studies. If found on a surgical excision and nothing more significant is found, no need for the pathologist to comment on margins and no need for re-excision in the vast majority of cases.

Ductal carcinoma in situ This term refers to a neoplastic proliferation of ductal cells that has not invaded beyond the confines of the duct. Studies show there is an increased relative risk (8- 10 times) for the subsequent development of invasive carcinoma. This risk applies to both breasts. However…… (next slide)

Ductal carcinoma in situ is also thought to be a PRECURSOR lesion to invasive carcinoma! This means most studies have shown that, if left untreated, ductal carcinoma in situ can progress to invasive carcinoma

Ductal carcinoma in situ: What does it mean if my biopsy shows this? If found on core needle biopsy, surgical excision is necessary. If found on a surgical excision, the size of DCIS, nuclear grade, presence of necrosis, and distance from all surgical margins should be reported by the pathologist. If margins are close, additional surgery may be needed. Radiation therapy may also be needed. In many cases, a medical oncologist may ask the pathologist to determine if the DCIS is estrogen receptor positive.

Now on to lobular…

Lobular hyperplasia Not a well-defined pathologic term Diagnosis not generally used

Atypical lobular hyperplasia A proliferation of small cells that begin to fill up but do not expand the milk-producing glands in the lobules. Studies show there is an increased relative risk (4- 5 times) for the subsequent development of invasive carcinoma, similar to atypical ductal hyperplasia. This risk applies to both breasts.

Atypical lobular hyperplasia: What does it mean if my biopsy shows this? If found on core needle biopsy, most doctors will recommend a surgical excision but this is somewhat controversial. If found on a surgical excision and nothing more significant is found, the pathologist does not need to comment on surgical margins, and no surgical re-excision is needed.

Lobular carcinoma in situ A proliferation of bland cells that fill up and expand at least 50% of the milk-producing glands in the lobules. Studies shows there is an increased relative risk (8-10 times) for the subsequent development of invasive carcinoma. This risk applies to both breasts.

Lobular carcinoma in situ

Lobular carcinoma in situ: What does it mean if my biopsy shows this? If found on core needle biopsy, most doctors will recommend a surgical excision but this is somewhat controversial. If found on a surgical excision and nothing more significant is found, the pathologist does not need to comment on surgical margins, and no surgical re-excision is needed.

Stay tuned for Part II which will cover invasive carcinomas…